Baillie Gifford & Co’s Veradigm Inc. Common Stock MDRX Stock Holding History
Bought
Maintained
Sold
Other funds holding MDRX
Baillie Gifford & Co's MDRX Position: Q2 2022 in Review
Baillie Gifford & Co sold out of Veradigm Inc. Common Stock (MDRX) in Q2 2022, closing a stake of 744 shares — an estimated $17K sold.
Baillie Gifford & Co first reported a position in MDRX in Q4 2020 and held it in 6 quarters. The position peaked at $17K in Q1 2022. 247 funds tracked by Wall St. Rank hold MDRX as of Q2 2022.
- Baillie Gifford & Co reported no remaining Veradigm Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
- Baillie Gifford & Co sold 744 Veradigm Inc. Common Stock shares in Q2 2022, an estimated $17K.
- Baillie Gifford & Co first reported a position in Veradigm Inc. Common Stock in Q4 2020 and held it in 6 quarters.
- Baillie Gifford & Co's Veradigm Inc. Common Stock position peaked at $17K in Q1 2022.
- 247 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q2 2022.
Based on Baillie Gifford & Co's 13F filing for Q2 2022, filed 8 Aug 2022.